Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1917 of 5804
-
Can vaccinated donor cells fight HPV cancers? early trial begins
Disease control OngoingIn this study, haploidentical relatives of a patient with recurrent or metastatic HPV 16-associated malignancy will be vaccinated with a therapeutic human papillomavirus (HPV) vaccine series to generate HPV-specific leukocytes. The cancer patient with recurrent or metastatic HPV1…
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New laser microscope could boost lung cancer detection during bronchoscopy
Diagnosis Recruiting nowThe goal of this multi-center randomized clinical trial is to evaluate the added value of needle based confocal laser endomicroscopy (nCLE)-imaging to regular diagnostic bronchoscopic peripheral lung lesion analysis on the diagnostic yield in patients with peripheral pulmonary no…
Phase: NA • Sponsor: Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New CT scan may spot hidden bleeding in stroke patients
Diagnosis CompletedThe goal of this clinical trial is to investigate the use of DECT (Dual-Energy Computed Tomography) in patients with acute ischemic stroke who receive an intervention (thrombolysis or thrombectomy). The main questions to answer are: 1. Can DECT more accurately differentiate hype…
Phase: NA • Sponsor: University of Manitoba • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
New program helps veterans hold onto PTSD gains with fewer doctor visits
Symptom relief CompletedPatients who complete prolonged exposure and cognitive processing therapy, the treatments for posttraumatic stress disorder (PTSD) with the most empirical support, continue to express a need for mental health treatment. A therapist-assisted self-management program for patients wh…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Can a hospital team boost HIV care and cut readmissions?
Disease control Recruiting nowExploring the effect of team-based ARTAS intervention in an inpatient setting on HIV linkage to care and hospital readmission rates.
Phase: NA • Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New mRNA flu shot enters early human testing
⭐️ VACCINE ⭐️ CompletedThis is a Phase 1, single-site, comparator-controlled, dosage-escalating study of an intramuscularly administered mRNA-LNP vaccine encoding for DCVC H1 HA in up to 50 adult volunteers aged 18 to 49 years, inclusive. This study is designed to assess the safety and immunogenicity o…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:01 UTC
-
Can blood tests predict liver Cancer's return?
Knowledge-focused OngoingThe investigators long-term goal is to identify molecular and immunological signatures that can be used as biomarkers to accurately predict early recurrence and inform immunotherapeutic strategies in patients with hepatocellular carcinoma (HCC) after hepatectomy. As an initial st…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Eye-Tracking test may spot vestibular migraine
Diagnosis CompletedIn the study, the investigators would like to examine whether there is a difference between patients with vestibular migraine, patients with episodic or chronic migraine and healthy subjects in the examination of videonystagmography, which has been used for many years to differen…
Sponsor: Dr. med. Lukas Becker • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New Weight-Loss shot shows promise in early trial
Disease control CompletedThis is a study of HS-20094 in participants with overweight and obesity. The main purpose is to learn more about how HS-20094 affects body weight. The study period including 4-12 weeks dose titration and 12-20 weeks maintain treatment and 6 weeks follow up.
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Scientists hunt for hidden clues to stop spreading stomach cancer
Knowledge-focused Recruiting nowThis is a pilot study aiming at identifying novel therapeutic molecular targets in patients with gastric cancer with lymph nodes or distant metastasis. All patients who are diagnosed with gastric cancer with metastases in the Prince of Wales Hospital will be screened for eligibil…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New sensor could spot hidden blood flow trouble after surgery
Knowledge-focused OngoingThe investigators will test if changes in CO2 is detected postoperatively in ischemic tissue in a reconstructed flap. IscAlert is measuring continuously CO2 in muscular and subcutaneous tissue. IscAlert is inserted distal to the operative field into normal muscle and/or subcutan…
Phase: NA • Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Heart drug could shield brain after bleeding stroke
Disease control Recruiting nowSub-arachnoid haemorrhage (SAH) are often due to ruptured intracerebral aneurysms and are associated with an importante morbi-mortality. SAH are often complicated by delayed cerebral ischemia (DCI) potentially due to cerebral vasospasm (CVS). A recent study showed that levosimend…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 14:54 UTC
-
Can a drug combo let HIV patients ditch daily meds?
Disease control TerminatedHuman immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic disease requiring lifelong therapy. The purpose of this study is to assess change in disease activity, adverse events, tolerability, …
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Blood test may predict when colorectal cancer treatment fails
Knowledge-focused OngoingCOPERNIC is an international, multicentre, single-arm study. Chemo-refractory mCRC subjects who meet all eligibility criteria will be treated with standard systemic chemotherapy (the decision about the treatment regimen being made by the treating physician) and undergo tumour ass…
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Mayo clinic launches massive genetic study to unlock cancer secrets
Knowledge-focused Recruiting nowThis study is being done to identify markers and causes of cancer by analyzing patient's DNA (i.e., genetic material), RNA, plasma, tissues, or other samples that could be informative for patients with cancer. Cancer genetic testing is a series of tests that finds specific change…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Zapping nerves with radiation may ease muscle stiffness
Symptom relief Recruiting nowA scientific study is being done to test a special treatment for people who have spasticity or tight muscles. This treatment is called "stereotactic radiosurgery dorsal rhizotomy." It uses very accurate beams of radiation to target certain nerves in the back to help loosen up the…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
One 2-hour zoom class may ease chronic migraine disability
Symptom relief OngoingPeople with chronic migraine headaches face many challenges, including high levels of daily pain, disturbances to everyday activities and sleep, and problems with mood such as depression or anxiety. This trial is being completed to study whether changing an individual's behaviors…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New hope for Hard-to-Treat colon cancer? study tests targeted drug combo
Disease control TerminatedThe purpose of this study is to measure tumor response to treatment with ompenaclid (RGX-202-01) in patients with previously treated RAS mutant advanced or metastatic CRC. All patients will receive treatment with FOLFIRI and bevacizumab. In addition, patients will be randomized t…
Phase: PHASE2 • Sponsor: Inspirna, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New cancer drug BRY812 enters first human trial
Disease control Recruiting nowThis is a Phase I, multicenter, open-label, single-arm and first-in-human clinical study of BRY812 for injection. The study objectives are to evaluate the safety, tolerability, pharmacokinetic profile, anti-tumor activity and immunogenicity of BRY812 for injection in patients wit…
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Real-world dupixent study tracks eczema improvement in 305 canadians
Disease control CompletedThis is a prospective, 18-month observational study of adult, adolescent and pediatric Canadian participants with Atopic Dermatitis (AD) commonly known as Eczema, who receive treatment with Dupixent for moderate-to-severe AD (msAD) according to the Canadian-specific prescribing i…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC